semaglutide shortage list fda glp 1 glp-1 shortage news november 2025 The FDA has removed injection products (GLP-1) from fda semaglutide shortage resolved feb

In SELECT, a trial of adults with overweight or obesity and established cardiovascular disease but no diabetes, once-weekly semaglutide 2.4 mg cut the primary composite of cardiovascular death, nonfatal heart attack, or nonfatal stroke to 6.5% versus 8.0% on placebo a hazard ratio of 0.80, roughly a 20% relative reduction

For those building muscle while on GLP-1 medications , the increased protein demands create another reason to prioritize hydration

Amazing staff, got a B12 shot and immediately noticed a difference

Chronic kidney disease 6

For someone starting at 250 pounds, that represents approximately 44 pounds